Although secondary hyperparathyroidism is evident in the majority of CKD patients and is associated with the genesis of MBD and MBD-related complications, the direct relation between PTH and cardiovascular complications or cardiovascular disease-related mortality in CKD is unclear and needs to be further studied. The gene discussed is PTH; the disease is secondary hyperparathyroidism.